Literature DB >> 11577478

Cancer statistics, 2001.

R T Greenlee1, M B Hill-Harmon, T Murray, M Thun.   

Abstract

Each year the American Cancer Society compiles estimates of the number of new cancer cases and deaths expected in the US in the current year and the most recent data on cancer incidence, mortality, and survival. An estimated 1,268,000 new cases of cancer will be diagnosed in the year 2001 and an estimated 553,400 Americans will die from cancer. Overall cancer incidence and death rates have continued to decrease in men and women since the early 1990s, and the decline in overall cancer mortality has been greater in recent years. Despite reductions in age-adjusted rates of cancer death, the total number of recorded cancer deaths in the US continues to increase, due to an aging and expanding population. Large disparities in cancer incidence and mortality across racial/ethnic groups continue. Black men and women experience higher incidence of cancer and poorer survival than white men and women. The disparity in survival reflects both diagnosis of cancer at later disease stages, and poorer survival within each stage of diagnosis.

Entities:  

Mesh:

Year:  2001        PMID: 11577478     DOI: 10.3322/canjclin.51.1.15

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  562 in total

Review 1.  Current and future strategies for combined-modality therapy in pancreatic cancer.

Authors:  Andrew H Ko; Margaret A Tempero
Journal:  Curr Oncol Rep       Date:  2002-05       Impact factor: 5.075

2.  Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.

Authors:  Amy L McDoniels-Silvers; Gary D Stoner; Ronald A Lubet; Ming You
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

Review 3.  Palliative surgery for cancer pain.

Authors:  Laurence McCahill; Betty Ferrell
Journal:  West J Med       Date:  2002-03

4.  Does PSA screening reduce prostate cancer mortality?

Authors:  André N Vis
Journal:  CMAJ       Date:  2002-03-05       Impact factor: 8.262

5.  A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity.

Authors:  C L Hsieh; I Oakley-Girvan; R R Balise; J Halpern; R P Gallagher; A H Wu; L N Kolonel; L E O'Brien; I G Lin; D J Van Den Berg; C Z Teh; D W West; A S Whittemore
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

Review 6.  A history of prostate cancer treatment.

Authors:  Samuel R Denmeade; John T Isaacs
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

Review 7.  A potential role of ruxolitinib in leukemia.

Authors:  Kiran Naqvi; Srdan Verstovsek; Hagop Kantarjian; Farhad Ravandi
Journal:  Expert Opin Investig Drugs       Date:  2011-06-03       Impact factor: 6.206

8.  Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer.

Authors:  Ning Li; Jie Ma; Maria A Guarnera; HongBin Fang; Ling Cai; Feng Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-27       Impact factor: 4.553

9.  Robotics in Colonoscopy.

Authors:  Dan Cater; Arpita Vyas; Dinesh Vyas
Journal:  Am J Robot Surg       Date:  2014-06

Review 10.  Beyond chemotherapy: targeted therapies in ovarian cancer.

Authors:  Timothy A Yap; Craig P Carden; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.